Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

20.14

+0.69 (3.55%)

At close: Nov 6, 2026, 4:00 PM EST

20.40

+0.26 (1.29%)

After-hours: Nov 6, 2026, 7:30 PM EST

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7,015	3,961	2,454	1,861	301	715
Market Cap Growth	91.05%	61.41%	31.88%	517.29%	-57.87%	6.05%
Enterprise Value	10,140	6,511	5,081	4,434	2,989	3,372
Last Close Price	20.14	12.60	7.92	6.07	1.99	4.79

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	50.47	54.97	-	-	-	67.35
Forward PE	17.75	15.04	11.69	11.92	2.71	5.65
PS Ratio	2.20	1.31	0.88	0.78	0.14	0.34
PB Ratio	12.73	664.26	-55.10	30.35	1.44	1.86
P/FCF Ratio	182.56	16.43	10.45	6.23	18.49	3.75
P/OCF Ratio	38.84	11.65	8.32	5.38	4.63	2.96
PEG Ratio	1.97	0.51	0.51	0.51	0.18	0.66

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.17	2.16	1.82	1.85	1.35	1.61
EV/EBITDA Ratio	13.72	10.11	8.69	9.05	6.79	7.49
EV/EBIT Ratio	18.59	15.48	14.59	17.03	14.94	15.57
EV/FCF Ratio	263.91	27.00	21.64	14.84	183.29	17.67

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	5.12	450.96	-58.22	44.87	13.62	7.52
Debt / EBITDA Ratio	4.32	4.06	4.31	5.43	6.15	6.15
Debt / FCF Ratio	85.44	11.15	11.05	9.21	174.50	15.13
Net Debt / Equity Ratio	4.88	402.92	-55.70	43.34	13.49	6.87
Net Debt / EBITDA Ratio	4.23	3.73	4.24	5.42	6.40	5.86
Net Debt / FCF Ratio	81.34	9.96	10.57	8.89	172.79	13.82
Asset Turnover	0.72	0.84	0.80	0.66	0.57	0.53
Inventory Turnover	2.90	3.10	2.98	2.77	2.79	2.67
Quick Ratio	1.05	1.39	0.82	0.87	1.10	1.39
Current Ratio	1.87	2.17	1.41	1.63	1.88	2.25
Return on Equity (ROE)	70.00%	-	-881.26%	-36.06%	-85.96%	5.45%
Return on Assets (ROA)	7.69%	7.32%	6.24%	4.48%	3.23%	3.41%
Return on Invested Capital (ROIC)	15.77%	16.18%	13.69%	9.07%	6.61%	4.62%
Return on Capital Employed (ROCE)	13.20%	15.00%	14.70%	9.90%	6.60%	6.60%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.98%	1.82%	-4.76%	-4.51%	-43.12%	1.49%
FCF Yield	0.55%	6.09%	9.57%	16.06%	5.41%	26.68%
Buyback Yield / Dilution	-4.13%	-5.12%	-75.42%	-16.69%	0.58%	-1.95%
Total Shareholder Return	-4.13%	-5.12%	-75.42%	-16.69%	0.58%	-1.95%

SEC Filings: 10-K · 10-Q